Results 71 to 80 of about 2,120,441 (365)
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source
Somatic mutational landscape in von Hippel–Lindau familial hemangioblastoma
The causes of central nervous system (CNS) hemangioblastoma in Von Hippel–Lindau (vHL) disease are unclear. We used Whole Exome Sequencing (WES) on familial hemangioblastoma to investigate events that underlie tumor development. Our findings suggest that VHL loss creates a permissive environment for tumor formation, while additional alterations ...
Maja Dembic +5 more
wiley +1 more source
Adaptive management of Ramsar wetlands [PDF]
The Macquarie Marshes are one of Australia’s iconic wetlands, recognised for their international importance, providing habitat for some of the continent’s more important waterbird breeding sites as well as complex and extensive flood-dependent vegetation
Gilad Bino +2 more
core
Linking drivers of food insecurity and ecosystem services in Africa
Food insecurity is a multidimensional and intricate problem, known to have significant implications for individuals, communities, and countries worldwide. Africa has become the continent that is experiencing this uncertainty the most.
Gregory Ayitey Aryee +2 more
doaj +1 more source
Hippo pathway at the crossroads of stemness and therapeutic resistance in breast cancer
Dysregulation of the Hippo pathway drives nuclear accumulation of YAP/TAZ, activating stemness‐related transcriptional programs that sustain breast cancer stemness and fuel therapeutic resistance across subtypes, underscoring Hippo signaling as a targetable vulnerability. Figure created and edited with BioRender.com.
Giulia Schiavoni +11 more
wiley +1 more source
In the present work, we have identified a transcriptional signature based on the differential expression of six genes (BCL2&MAST4, HSH2D&LAT2, METRN&PITPNM2) that would facilitate the early detection of T‐cell acute lymphoblastic leukemia (T‐ALL) patients prone to a poor treatment response and could be implemented at diagnosis, along with other risk ...
Antonio Lahera +11 more
wiley +1 more source
Diagnosing resistance to change in the change management process
This article explains the change management process and resistance to organizational change through examining causes of resistance to change, diagnosing them, and finding the ways to deal with resistance to change.
Кужда, Тетяна Іванівна
core
Readiness for change : an individual perspective [PDF]
viii, 84 leaves ; 29 cm.The purpose of this study is to understand employees’ views of their readiness for change. The study explores employees’ retrospective interpretations of their experience with the elimination of the public service division of an ...
University of Lethbridge. Faculty of Management +1 more
core
Organisational Change Management: A Critical Review
It can be argued that the successful management of change is crucial to any organisation in order to survive and succeed in the present highly competitive and continuously evolving business environment.
BY, Rune, By, Rune T., By, Rune T
core +1 more source
Hijacking emergency granulopoiesis: Neutrophil ontogeny and reprogramming in cancer
Neutrophils are highly plastic innate immune cells; their functions in cancer extend beyond the tumour microenvironment. This Review summarises current understanding of neutrophil maturation and heterogeneity and highlights tumour‐induced granulopoiesis as a systemic programme that expands immature, immunosuppressive neutrophils via tumour‐derived ...
Gabriela Marinescu, Yi Feng
wiley +1 more source

